Evaluating the benefit of immunotherapy for Stage III melanoma, Table 1

Published: 4 June 2024| Version 1 | DOI: 10.17632/t4wkdp4mf9.1
Contributors:
Amar Desai,

Description

Table 1 for "Evaluating the benefit of immunotherapy for Stage III melanoma" published in JAAD

Files

Categories

Dermatology, Immunotherapy, Melanoma

Licence